745264
Last Update Posted: 2009-03-20
Recruiting has ended
All Genders accepted | 18 Years-55 Years |
80 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise
- Comparison of the plasma PK after single use of 100 mg ketoprofen from Diractin®. 50 mg applied on 2 major joints to
- 400 mg ketoprofen from Diractin® (100 mg applied to 4 joints - overexposure)
- 100 mg and 400 mg ketoprofen from Diractin® used concomitant with heat application
- 100 mg and 400 mg ketoprofen from Diractin® used concomitant with moderate exercise
Eligibility
Relevant conditions:
Pharmacokinetic
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov